{"gene":"ARPC5","run_date":"2026-06-09T22:02:44","timeline":{"discoveries":[{"year":2003,"finding":"MAPKAPK2 (MK2) directly phosphorylates the A isoform (ARPC5A/p16-Arc) but not the B isoform of ARPC5 at serine-77; mutation of Ser-77 to alanine abolishes phosphorylation. MAPKAPK2 also phosphorylates ARPC5 within intact Arp2/3 complexes precipitated from neutrophil lysates.","method":"In vitro kinase assay with recombinant MAPKAPK2, 2D electrophoresis, MALDI-MS peptide fingerprinting, site-directed mutagenesis (S77A), Co-IP of Arp2/3 complex from neutrophil lysates","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Strong — in vitro phosphorylation assay with mutagenesis confirming the phospho-site, plus confirmation in intact native complex; multiple orthogonal methods in one study","pmids":["12829704"],"is_preprint":false},{"year":2003,"finding":"ARPC5 exists as two isoforms (ARPC5A and ARPC5B) that are both incorporated into the Arp2/3 complex purified from human neutrophils, demonstrating that mammalian cells contain multiple compositionally distinct Arp2/3 complexes. Both isoforms co-localize with Arp2/3 complex in C2C12 cells when myc-tagged.","method":"Arp2/3 complex affinity purification from neutrophil extract, isoform-specific antibody generation, Western blot tissue distribution analysis, immunofluorescence co-localization in C2C12 cells","journal":"Cell motility and the cytoskeleton","confidence":"High","confidence_rationale":"Tier 2 / Strong — affinity purification of native complex plus specific antibodies and immunofluorescence co-localization, multiple orthogonal methods","pmids":["12451597"],"is_preprint":false},{"year":2011,"finding":"PKC phosphorylates ARPC5 in neointimal smooth muscle cells, and this phosphorylation is required for rear polarization of the MTOC. A non-phosphorylatable ARPC5 mutant abolishes rear MTOC polarization and directional migration of neointimal SMCs, linking ARPC5 phosphorylation to cytoskeletal organization underlying cell polarity.","method":"Phosphoproteomic screening, mass spectrometry, RNA silencing of ARPC5, transfection with non-phosphorylatable ARPC5 mutant, PKC inhibition, immunofluorescence of MTOC orientation","journal":"The American journal of pathology","confidence":"High","confidence_rationale":"Tier 2 / Moderate — phosphoproteomics plus functional rescue with phospho-dead mutant plus RNAi phenotype, multiple orthogonal methods in a single study","pmids":["21281821"],"is_preprint":false},{"year":2012,"finding":"ARPC5 is a direct target of miR-133a; luciferase reporter assay confirmed direct binding. Silencing ARPC5 inhibits cell migration and invasion in HNSCC lines and causes reorganization of the actin cytoskeleton to a round, bleb-like morphology.","method":"Genome-wide gene expression analysis, bioinformatics, luciferase reporter assay (3'UTR), siRNA knockdown, migration/invasion assays, actin cytoskeleton imaging","journal":"International journal of oncology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — luciferase reporter validates direct miRNA target, functional KD confirms actin and migration phenotype, single lab","pmids":["22378351"],"is_preprint":false},{"year":2012,"finding":"ARPC5 functions as a broadly acting translational suppressor in male germ cells: it inhibits translation initiation by blocking 80S ribosome formation and facilitates transport of mRNAs to chromatoid/P bodies. Loss of microRNA-dependent regulation of Arpc5 disrupts sequestration of germ cell mRNAs into translationally inert ribonucleoprotein particles, resulting in abnormal round spermatid differentiation and impaired fertility.","method":"Mouse genetics (loss-of-function), polysome profiling (80S formation assay), RNA immunoprecipitation, fluorescence imaging of chromatoid/P bodies, fertility assays","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal methods (polysome profiling, RIP, live imaging, genetic KO with defined cellular and organismal phenotype) establishing a non-canonical translational regulatory role","pmids":["22447776"],"is_preprint":false},{"year":2023,"finding":"ARPC5 and ARPC5L isoforms differentially regulate Arp2/3 complex-dependent cell migration: both isoforms determine the structural stability of ArpC1 in actin branch junctions and influence protrusion characteristics and actin network ultrastructure. Additionally, ArpC5 isoforms differentially position Ena/VASP family proteins at the leading edge, and Ena/VASP mediates isoform-specific effects on actin assembly levels.","method":"Reverse genetics (CRISPR/siRNA), cellular cryo-electron tomography (cryo-ET), live-cell imaging, FRAP, immunofluorescence, migration assays","journal":"Science advances","confidence":"High","confidence_rationale":"Tier 1 / Strong — cryo-ET structural biology combined with reverse genetics and live imaging, multiple orthogonal methods establishing mechanism","pmids":["36662867"],"is_preprint":false},{"year":2023,"finding":"ARPC5 and ARPC5L isoforms play distinct roles in CD4 T cells: ARPC5 drives cytoplasmic actin dynamics after TCR stimulation and mediates nuclear actin polymerization triggered by DNA replication stress, while ARPC5L specifically drives nuclear actin polymerization upon TCR stimulation via a calcium-calmodulin-N-WASP signaling pathway.","method":"Isoform-specific siRNA knockdown, live-cell fluorescence imaging of actin (nuclear vs cytoplasmic), calcium-calmodulin pathway inhibitors, N-WASP inhibition/knockdown, cytokine expression assays","journal":"eLife","confidence":"High","confidence_rationale":"Tier 2 / Strong — isoform-specific genetic depletion with pathway dissection (calcium-calmodulin-N-WASP), multiple orthogonal methods, defines distinct subcellular mechanistic roles","pmids":["37162507"],"is_preprint":false},{"year":2023,"finding":"Germline biallelic null mutations in ARPC5 disrupt Arp2/3 complex conformation and function; reestablishment of ARPC5 expression in vitro rescues Arp2/3 complex conformation and functions. ARPC5 deficiency also selectively impairs IL-6 classical signaling but not IL-6 trans-signaling.","method":"Human genetics (biallelic null patients), in vitro complementation (ARPC5 re-expression), Arp2/3 complex functional assays, IL-6 signaling pathway dissection","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 2 / Strong — human null mutations with in vitro rescue of Arp2/3 complex function, plus mechanistic pathway dissection of IL-6 signaling, multiple orthogonal methods","pmids":["37349293"],"is_preprint":false},{"year":2025,"finding":"Cryo-EM structures at 2.9-Å resolution reveal that NPF binding to Arp2 is allosterically linked to the release of ArpC5's N-terminal tail from Arp2 and induces conformational changes in Arp2 including closure of its ATP-binding cleft and partial rotation/translation toward the active-complex position. This defines ArpC5's N-terminal tail as an inhibitory element whose release is part of the allosteric activation mechanism of Arp2/3 complex.","method":"Cryo-electron microscopy (cryo-EM) at 2.9-Å resolution, structural comparison of two states (with and without NPF bound to Arp2)","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1 / Moderate — high-resolution cryo-EM structures with two distinct states and allosteric mechanism identified; single study but Tier 1 structural method","pmids":["40042350"],"is_preprint":false},{"year":2023,"finding":"KLF4 transcriptionally activates ARPC5 by binding to its promoter region, as demonstrated by chromatin immunoprecipitation and luciferase reporter assay. ARPC5 in turn upregulates ADAM17 as a downstream effector to promote prostate cancer cell migration and invasion.","method":"Chromatin immunoprecipitation (ChIP), luciferase reporter assay, shRNA knockdown, ADAM17 overexpression rescue, xenograft mouse model","journal":"Apoptosis","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP and luciferase confirm direct transcriptional regulation; downstream ADAM17 link confirmed by rescue experiments; single lab","pmids":["36881291"],"is_preprint":false},{"year":2023,"finding":"CPEB2 promotes ARPC5 mRNA stability through direct interaction, as shown by RNA immunoprecipitation and co-localization in the cytoplasm, and actinomycin D chase experiments demonstrating increased ARPC5 mRNA half-life when CPEB2 is expressed.","method":"RNA immunoprecipitation (RIP), FISH co-localization, actinomycin D mRNA stability assay, cycloheximide chase, shRNA knockdown/overexpression rescue","journal":"Journal of orthopaedic surgery and research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — RIP and mRNA stability assay establish post-transcriptional regulation mechanism; single lab, multiple orthogonal methods","pmids":["37231521"],"is_preprint":false},{"year":2024,"finding":"TAGLN2 (transgelin-2) physically interacts with ARPC5 and promotes its expression, activating the MEK/ERK signaling pathway to drive pancreatic cancer cell proliferation, invasion, and metastasis. Silencing ARPC5 reverses TAGLN2 overexpression-induced effects.","method":"Co-immunoprecipitation (Co-IP), immunofluorescence, protein profiling, shRNA knockdown, MEK inhibitor (U0126), lentiviral overexpression, in vivo xenograft","journal":"Cellular signalling","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — Co-IP establishes interaction; downstream MEK/ERK pathway link and functional rescue with ARPC5 KD; single lab","pmids":["38744388"],"is_preprint":false},{"year":2024,"finding":"Arp2/3 complexes containing Arpc5 (but not the Arpc5l isoform) are required for macrophage phagocytosis and killing of intracellular bacteria; loss of Arpc5 in the murine hematopoietic system leads to failure of macrophages to restrict microbial invasion, causing intestinal inflammation and demonstrating an isoform-specific role for ARPC5-containing Arp2/3 complexes in innate immune defense.","method":"Conditional knockout (hematopoietic-specific Arpc5 vs Arpc5l deletion in mice), phagocytosis assays, intracellular bacterial killing assays, histopathology, in vivo mouse model","journal":"bioRxiv","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — conditional KO with isoform specificity comparison and direct phagocytosis/killing assays; preprint, not yet peer-reviewed","pmids":["bio_10.1101_2024.07.18.604111"],"is_preprint":true},{"year":2024,"finding":"Arpc5-containing Arp2/3 complexes in the actomyosin cortex act as a gatekeeper for membrane availability required for t-tubule growth in muscle cells; disruption of Arpc5 leads to enlarged t-tubules and impaired synchronization between plasma membrane depolarization and calcium release, causing muscle fatigue.","method":"Conditional postnatal knockout of Arpc5 in myofibers (mice), electron microscopy of t-tubules, calcium imaging, muscle fatigue/force measurements","journal":"bioRxiv","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — conditional KO with defined structural and functional phenotype in muscle; preprint, single study","pmids":["bio_10.1101_2024.08.13.607563"],"is_preprint":true}],"current_model":"ARPC5 (p16-Arc) is the smallest subunit of the seven-member Arp2/3 actin-nucleation complex, where its N-terminal tail contacts Arp2 and acts as an inhibitory element whose release—upon NPF binding to Arp2—is allosterically coupled to Arp2/3 activation; it exists as two isoforms (ARPC5A/ARPC5 and ARPC5B/ARPC5L) that are incorporated into compositionally distinct Arp2/3 complexes with different cellular functions: ARPC5 drives cytoplasmic actin dynamics, phagocytosis, and t-tubule membrane homeostasis, while ARPC5L mediates nuclear actin polymerization downstream of TCR/calcium-calmodulin-N-WASP signaling; both isoforms regulate actin branch junction stability, Ena/VASP positioning, and protrusion dynamics; ARPC5 is phosphorylated by MAPKAPK2 at Ser-77 and by PKC, the latter being required for rear MTOC polarization and directional migration; and ARPC5 has an unconventional translational suppressor role in spermatids where it blocks 80S ribosome formation and sequesters mRNAs into P bodies."},"narrative":{"mechanistic_narrative":"ARPC5 (p16-Arc) is the smallest subunit of the Arp2/3 actin-nucleation complex, and within that complex its N-terminal tail functions as an autoinhibitory element whose release upon nucleation-promoting-factor binding to Arp2 is allosterically coupled to complex activation, with closure of the Arp2 ATP-binding cleft and rotation toward the active conformation [PMID:40042350]. Mammalian cells contain two compositionally distinct Arp2/3 complexes built around the ARPC5 and ARPC5L isoforms, both incorporated into native complexes purified from neutrophils [PMID:12451597], and these isoforms carry out divergent cellular functions: ARPC5-containing complexes stabilize ArpC1 at actin branch junctions, position Ena/VASP proteins at the leading edge, and shape protrusion dynamics during migration [PMID:36662867], drive cytoplasmic actin dynamics after TCR stimulation while ARPC5L specifically mediates nuclear actin polymerization through a calcium-calmodulin-N-WASP pathway [PMID:37162507]. ARPC5 activity is set post-translationally by phosphorylation: MAPKAPK2 phosphorylates the A isoform at Ser-77 [PMID:12829704], and PKC phosphorylation is required for rear MTOC polarization and directional migration [PMID:21281821]. Biallelic null mutations in ARPC5 disrupt Arp2/3 complex conformation and selectively impair IL-6 classical signaling, with re-expression rescuing complex function, defining ARPC5 deficiency as a cause of human disease [PMID:37349293]. Beyond its structural role in actin nucleation, ARPC5 has an unconventional function as a translational suppressor in male germ cells, where it blocks 80S ribosome formation and routes mRNAs into chromatoid/P bodies, a microRNA-controlled activity required for normal spermatid differentiation and fertility [PMID:22447776].","teleology":[{"year":2003,"claim":"Establishing that ARPC5 exists as two distinct isoforms both built into native Arp2/3 complexes revealed that mammalian cells assemble compositionally heterogeneous nucleation machines rather than a single uniform complex.","evidence":"Affinity purification of Arp2/3 from neutrophils, isoform-specific antibodies, and immunofluorescence co-localization in C2C12 cells","pmids":["12451597"],"confidence":"High","gaps":["Did not assign distinct functions to the two isoforms","Tissue-specific isoform expression ratios not resolved"]},{"year":2003,"claim":"Identification of MAPKAPK2 phosphorylation of ARPC5A at Ser-77, but not the B isoform, showed that the two isoforms are differentially regulated by signaling kinases even within intact complexes.","evidence":"In vitro kinase assays with recombinant MAPKAPK2, MALDI-MS, S77A mutagenesis, and Co-IP of native Arp2/3 from neutrophils","pmids":["12829704"],"confidence":"High","gaps":["Functional consequence of Ser-77 phosphorylation for actin nucleation not defined","Upstream stimulus driving MK2-ARPC5 phosphorylation in vivo not established"]},{"year":2011,"claim":"Linking PKC phosphorylation of ARPC5 to rear MTOC polarization connected a post-translational modification of this subunit to directional cell migration.","evidence":"Phosphoproteomics, ARPC5 RNAi, phospho-dead mutant rescue, and PKC inhibition in neointimal smooth muscle cells","pmids":["21281821"],"confidence":"High","gaps":["PKC phospho-site on ARPC5 not mapped here","Mechanistic link between ARPC5 phosphorylation and MTOC positioning unresolved"]},{"year":2012,"claim":"Discovery that ARPC5 acts as a translational suppressor in spermatids established a non-canonical, actin-independent role distinct from its Arp2/3 function.","evidence":"Mouse loss-of-function genetics, polysome profiling, RNA immunoprecipitation, and P-body imaging with fertility assays","pmids":["22447776"],"confidence":"High","gaps":["Molecular mechanism by which ARPC5 blocks 80S assembly unknown","Whether this role requires Arp2/3 incorporation not addressed"]},{"year":2012,"claim":"Validation of ARPC5 as a direct miR-133a target with migration/invasion phenotypes placed it within a cancer-relevant cytoskeletal regulatory axis.","evidence":"3'UTR luciferase reporter, siRNA knockdown, and migration/invasion plus actin morphology assays in HNSCC lines","pmids":["22378351"],"confidence":"Medium","gaps":["Single-lab correlative cancer context","Did not connect actin phenotype to a specific Arp2/3 mechanism"]},{"year":2023,"claim":"Cryo-ET combined with reverse genetics defined how the ARPC5 and ARPC5L isoforms differentially set branch-junction stability and Ena/VASP positioning, giving isoform identity a structural and mechanistic basis in migration.","evidence":"CRISPR/siRNA depletion, cellular cryo-electron tomography, FRAP, and live-cell migration imaging","pmids":["36662867"],"confidence":"High","gaps":["Atomic basis for how isoforms alter ArpC1 stability not resolved","How Ena/VASP is recruited isoform-specifically unclear"]},{"year":2023,"claim":"Dissection in CD4 T cells showed ARPC5 and ARPC5L drive distinct cytoplasmic versus nuclear actin programs downstream of separable signaling inputs, demonstrating spatial division of labor between the isoforms.","evidence":"Isoform-specific siRNA, compartment-resolved live actin imaging, and calcium-calmodulin/N-WASP pathway perturbation","pmids":["37162507"],"confidence":"High","gaps":["How isoform composition is selected for nuclear vs cytoplasmic pools unknown","Downstream transcriptional consequences of nuclear actin not detailed"]},{"year":2023,"claim":"Human biallelic null mutations with in vitro rescue established ARPC5 as essential for proper Arp2/3 conformation and as a determinant of IL-6 classical signaling, defining a human disease connection.","evidence":"Patient genetics, ARPC5 re-expression complementation, Arp2/3 functional assays, and IL-6 signaling dissection","pmids":["37349293"],"confidence":"High","gaps":["Mechanism linking Arp2/3 to IL-6 classical vs trans-signaling not fully resolved","Full clinical spectrum of deficiency not mapped"]},{"year":2023,"claim":"Identification of KLF4 as a direct transcriptional activator and ADAM17 as a downstream effector placed ARPC5 in a defined transcription-to-invasion axis in prostate cancer.","evidence":"ChIP, promoter luciferase assays, shRNA knockdown, ADAM17 rescue, and xenografts","pmids":["36881291"],"confidence":"Medium","gaps":["Single-lab cancer context","Whether ADAM17 effect depends on Arp2/3 actin function unclear"]},{"year":2023,"claim":"Demonstration that CPEB2 binds and stabilizes ARPC5 mRNA added a post-transcriptional layer controlling ARPC5 abundance.","evidence":"RNA immunoprecipitation, FISH co-localization, and actinomycin D mRNA stability chase with knockdown/overexpression rescue","pmids":["37231521"],"confidence":"Medium","gaps":["Single-lab finding","Physiological context where CPEB2 controls ARPC5 not established"]},{"year":2024,"claim":"TAGLN2 was shown to physically interact with ARPC5 and drive MEK/ERK-dependent tumor progression, linking ARPC5 to a proliferation/invasion signaling pathway.","evidence":"Co-IP, immunofluorescence, shRNA knockdown, MEK inhibition, and xenografts in pancreatic cancer","pmids":["38744388"],"confidence":"Medium","gaps":["Single Co-IP-based interaction without structural mapping","Direct vs indirect coupling of ARPC5 to MEK/ERK unresolved"]},{"year":2024,"claim":"Isoform-resolved conditional knockouts defined ARPC5-specific (not ARPC5L) roles in macrophage phagocytosis/bacterial killing and in t-tubule membrane homeostasis, extending isoform specialization to innate immunity and muscle physiology.","evidence":"Hematopoietic- and myofiber-specific conditional Arpc5 deletion, phagocytosis/killing assays, t-tubule EM, and calcium/fatigue measurements (preprints)","pmids":["bio_10.1101_2024.07.18.604111","bio_10.1101_2024.08.13.607563"],"confidence":"Medium","gaps":["Both findings are preprints not yet peer-reviewed","Molecular basis for ARPC5 over ARPC5L preference in these tissues unknown"]},{"year":2025,"claim":"High-resolution cryo-EM structures resolved how NPF binding to Arp2 triggers release of the ARPC5 N-terminal tail, defining it as an inhibitory element released during allosteric activation of the complex.","evidence":"2.9-Å cryo-EM structures comparing NPF-bound and unbound Arp2 states","pmids":["40042350"],"confidence":"High","gaps":["Whether ARPC5 vs ARPC5L tails differ in this inhibitory mechanism not addressed","Kinetics of tail release during nucleation not measured"]},{"year":null,"claim":"How a cell selects ARPC5 versus ARPC5L for incorporation into Arp2/3 complexes, and how this choice is coordinated with the kinase, microRNA, and transcriptional inputs that regulate ARPC5, remains unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No mechanism for isoform selection during complex assembly","Integration of phospho-regulation with isoform-specific functions not established","Relationship between the actin-nucleation and translational-suppressor roles unknown"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0005198","term_label":"structural molecule activity","supporting_discovery_ids":[1,5,8]},{"term_id":"GO:0008092","term_label":"cytoskeletal protein binding","supporting_discovery_ids":[5,8]},{"term_id":"GO:0045182","term_label":"translation regulator activity","supporting_discovery_ids":[4]}],"localization":[{"term_id":"GO:0005856","term_label":"cytoskeleton","supporting_discovery_ids":[1,5]},{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[6]},{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[6]}],"pathway":[{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[6,7]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[2,11]}],"complexes":["Arp2/3 complex"],"partners":["ARPC1","TAGLN2","CPEB2"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"O15511","full_name":"Actin-related protein 2/3 complex subunit 5","aliases":["Arp2/3 complex 16 kDa subunit","p16-ARC"],"length_aa":151,"mass_kda":16.3,"function":"Component of the Arp2/3 complex, a multiprotein complex that mediates actin polymerization upon stimulation by nucleation-promoting factor (NPF) (PubMed:9230079). The Arp2/3 complex mediates the formation of branched actin networks in the cytoplasm, providing the force for cell motility (PubMed:9230079). In addition to its role in the cytoplasmic cytoskeleton, the Arp2/3 complex also promotes actin polymerization in the nucleus, thereby regulating gene transcription and repair of damaged DNA (PubMed:29925947). The Arp2/3 complex promotes homologous recombination (HR) repair in response to DNA damage by promoting nuclear actin polymerization, leading to drive motility of double-strand breaks (DSBs) (PubMed:29925947)","subcellular_location":"Cytoplasm, cytoskeleton; Cell projection; Nucleus","url":"https://www.uniprot.org/uniprotkb/O15511/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/ARPC5","classification":"Not Classified","n_dependent_lines":49,"n_total_lines":1208,"dependency_fraction":0.04056291390728477},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[{"gene":"ACTR2","stoichiometry":10.0},{"gene":"ARPC2","stoichiometry":10.0},{"gene":"ARPC3","stoichiometry":10.0},{"gene":"USP22","stoichiometry":4.0},{"gene":"ACTG1","stoichiometry":0.2},{"gene":"ACTN4","stoichiometry":0.2},{"gene":"CALD1","stoichiometry":0.2},{"gene":"CALM3","stoichiometry":0.2},{"gene":"CAPZB","stoichiometry":0.2},{"gene":"CDC42","stoichiometry":0.2}],"url":"https://opencell.sf.czbiohub.org/search/ARPC5","total_profiled":1310},"omim":[{"mim_id":"621450","title":"ACTIN-RELATED PROTEIN 2/3 COMPLEX, SUBUNIT 5-LIKE; ARPC5L","url":"https://www.omim.org/entry/621450"},{"mim_id":"620565","title":"IMMUNODEFICIENCY 113 WITH AUTOIMMUNITY AND AUTOINFLAMMATION; IMD113","url":"https://www.omim.org/entry/620565"},{"mim_id":"604227","title":"ACTIN-RELATED PROTEIN 2/3 COMPLEX, SUBUNIT 5; ARPC5","url":"https://www.omim.org/entry/604227"},{"mim_id":"604226","title":"ACTIN-RELATED PROTEIN 2/3 COMPLEX, SUBUNIT 4; ARPC4","url":"https://www.omim.org/entry/604226"},{"mim_id":"604225","title":"ACTIN-RELATED PROTEIN 2/3 COMPLEX, SUBUNIT 3; ARPC3","url":"https://www.omim.org/entry/604225"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Approved","locations":[{"location":"Vesicles","reliability":"Approved"},{"location":"Plasma membrane","reliability":"Approved"},{"location":"Cell Junctions","reliability":"Approved"},{"location":"Cytosol","reliability":"Approved"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/ARPC5"},"hgnc":{"alias_symbol":["p16-Arc","ARC16","dJ127C7.3"],"prev_symbol":[]},"alphafold":{"accession":"O15511","domains":[{"cath_id":"1.25.40.190","chopping":"35-145","consensus_level":"high","plddt":96.279,"start":35,"end":145}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/O15511","model_url":"https://alphafold.ebi.ac.uk/files/AF-O15511-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-O15511-F1-predicted_aligned_error_v6.png","plddt_mean":92.19},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=ARPC5","jax_strain_url":"https://www.jax.org/strain/search?query=ARPC5"},"sequence":{"accession":"O15511","fasta_url":"https://rest.uniprot.org/uniprotkb/O15511.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/O15511/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/O15511"}},"corpus_meta":[{"pmid":"22378351","id":"PMC_22378351","title":"Actin-related protein 2/3 complex subunit 5 (ARPC5) contributes to cell migration and invasion and is directly regulated by tumor-suppressive microRNA-133a in head and neck squamous cell carcinoma.","date":"2012","source":"International journal of oncology","url":"https://pubmed.ncbi.nlm.nih.gov/22378351","citation_count":74,"is_preprint":false},{"pmid":"12829704","id":"PMC_12829704","title":"Identification of the p16-Arc subunit of the Arp 2/3 complex as a substrate of MAPK-activated protein kinase 2 by proteomic analysis.","date":"2003","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/12829704","citation_count":47,"is_preprint":false},{"pmid":"12451597","id":"PMC_12451597","title":"Identification and characterisation of a novel human isoform of Arp2/3 complex subunit p16-ARC/ARPC5.","date":"2003","source":"Cell motility and the cytoskeleton","url":"https://pubmed.ncbi.nlm.nih.gov/12451597","citation_count":35,"is_preprint":false},{"pmid":"21281821","id":"PMC_21281821","title":"Rear polarization of the microtubule-organizing center in neointimal smooth muscle cells depends on PKCα, ARPC5, and RHAMM.","date":"2011","source":"The American journal of pathology","url":"https://pubmed.ncbi.nlm.nih.gov/21281821","citation_count":30,"is_preprint":false},{"pmid":"22447776","id":"PMC_22447776","title":"Interaction between microRNAs and actin-associated protein Arpc5 regulates translational suppression during male germ cell differentiation.","date":"2012","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/22447776","citation_count":28,"is_preprint":false},{"pmid":"36662867","id":"PMC_36662867","title":"ArpC5 isoforms regulate Arp2/3 complex-dependent protrusion through differential Ena/VASP positioning.","date":"2023","source":"Science advances","url":"https://pubmed.ncbi.nlm.nih.gov/36662867","citation_count":22,"is_preprint":false},{"pmid":"34468072","id":"PMC_34468072","title":"YAP facilitates melanoma migration through regulation of actin-related protein 2/3 complex subunit 5 (ARPC5).","date":"2021","source":"Pigment cell & melanoma research","url":"https://pubmed.ncbi.nlm.nih.gov/34468072","citation_count":22,"is_preprint":false},{"pmid":"37162507","id":"PMC_37162507","title":"ARPC5 isoforms and their regulation by calcium-calmodulin-N-WASP drive distinct Arp2/3-dependent actin remodeling events in CD4 T cells.","date":"2023","source":"eLife","url":"https://pubmed.ncbi.nlm.nih.gov/37162507","citation_count":19,"is_preprint":false},{"pmid":"37349293","id":"PMC_37349293","title":"Inherited ARPC5 mutations cause an actinopathy impairing cell motility and disrupting cytokine signaling.","date":"2023","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/37349293","citation_count":13,"is_preprint":false},{"pmid":"37231521","id":"PMC_37231521","title":"CPEB2 enhances cell growth and angiogenesis by upregulating ARPC5 mRNA stability in multiple myeloma.","date":"2023","source":"Journal of orthopaedic surgery and research","url":"https://pubmed.ncbi.nlm.nih.gov/37231521","citation_count":8,"is_preprint":false},{"pmid":"36881291","id":"PMC_36881291","title":"ARPC5 is transcriptionally activated by KLF4, and promotes cell migration and invasion in prostate cancer via up-regulating ADAM17 : ARPC5 serves as an oncogene in prostate cancer.","date":"2023","source":"Apoptosis : an international journal on programmed cell death","url":"https://pubmed.ncbi.nlm.nih.gov/36881291","citation_count":8,"is_preprint":false},{"pmid":"23459330","id":"PMC_23459330","title":"Effects of hypothyroidism on expression of CRMP2B and ARPC5 during development of the rat frontal cortex.","date":"2013","source":"International journal of biological sciences","url":"https://pubmed.ncbi.nlm.nih.gov/23459330","citation_count":8,"is_preprint":false},{"pmid":"38744388","id":"PMC_38744388","title":"TAGLN2 targeted control of ARPC5-mediated activation of the MEK/ERK signaling pathway influences the proliferation, invasion, and metastasis of pancreatic cancer cells.","date":"2024","source":"Cellular signalling","url":"https://pubmed.ncbi.nlm.nih.gov/38744388","citation_count":6,"is_preprint":false},{"pmid":"36605483","id":"PMC_36605483","title":"Long noncoding RNA DSCR8 promotes the proliferation of liver cancer cells and inhibits apoptosis via the miR-22-3p/ARPC5 Axis.","date":"2023","source":"Journal of Cancer","url":"https://pubmed.ncbi.nlm.nih.gov/36605483","citation_count":6,"is_preprint":false},{"pmid":"40042350","id":"PMC_40042350","title":"NPF binding to Arp2 is allosterically linked to the release of ArpC5's N-terminal tail and conformational changes in Arp2/3 complex.","date":"2025","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/40042350","citation_count":4,"is_preprint":false},{"pmid":"37081667","id":"PMC_37081667","title":"MiR-145 regulates steroidogenesis in mouse primary granulosa cells by targeting Arpc5 and subsequent cytoskeleton remodeling.","date":"2023","source":"The Journal of reproduction and development","url":"https://pubmed.ncbi.nlm.nih.gov/37081667","citation_count":2,"is_preprint":false},{"pmid":"41403630","id":"PMC_41403630","title":"LncRNA NEAT1 contributes to multiple myeloma progression via upregulating ARPC5 by sponging miR-133a.","date":"2024","source":"Archives of medical science : AMS","url":"https://pubmed.ncbi.nlm.nih.gov/41403630","citation_count":0,"is_preprint":false},{"pmid":null,"id":"bio_10.1101_2025.08.07.669089","title":"Integrative analysis of gene networks associated with adipose and muscle traits in Hanwoo steers","date":"2025-08-10","source":"bioRxiv","url":"https://doi.org/10.1101/2025.08.07.669089","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2024.08.13.607563","title":"The actomyosin cortex controls t-tubule remodeling in muscle","date":"2024-08-13","source":"bioRxiv","url":"https://doi.org/10.1101/2024.08.13.607563","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2024.07.18.604111","title":"Branched actin networks mediate macrophage-dependent host microbiota homeostasis","date":"2024-07-18","source":"bioRxiv","url":"https://doi.org/10.1101/2024.07.18.604111","citation_count":0,"is_preprint":true}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":11661,"output_tokens":3974,"usd":0.047296,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":11762,"output_tokens":4348,"usd":0.083755,"stage2_stop_reason":"end_turn"},"total_usd":0.131051,"stage1_batch_id":"msgbatch_0179Z2pxRYBsXi2xADneafRw","stage2_batch_id":"msgbatch_01LaY9ZaVdgjWArcZo9eqQE5","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2003,\n      \"finding\": \"MAPKAPK2 (MK2) directly phosphorylates the A isoform (ARPC5A/p16-Arc) but not the B isoform of ARPC5 at serine-77; mutation of Ser-77 to alanine abolishes phosphorylation. MAPKAPK2 also phosphorylates ARPC5 within intact Arp2/3 complexes precipitated from neutrophil lysates.\",\n      \"method\": \"In vitro kinase assay with recombinant MAPKAPK2, 2D electrophoresis, MALDI-MS peptide fingerprinting, site-directed mutagenesis (S77A), Co-IP of Arp2/3 complex from neutrophil lysates\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — in vitro phosphorylation assay with mutagenesis confirming the phospho-site, plus confirmation in intact native complex; multiple orthogonal methods in one study\",\n      \"pmids\": [\"12829704\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"ARPC5 exists as two isoforms (ARPC5A and ARPC5B) that are both incorporated into the Arp2/3 complex purified from human neutrophils, demonstrating that mammalian cells contain multiple compositionally distinct Arp2/3 complexes. Both isoforms co-localize with Arp2/3 complex in C2C12 cells when myc-tagged.\",\n      \"method\": \"Arp2/3 complex affinity purification from neutrophil extract, isoform-specific antibody generation, Western blot tissue distribution analysis, immunofluorescence co-localization in C2C12 cells\",\n      \"journal\": \"Cell motility and the cytoskeleton\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — affinity purification of native complex plus specific antibodies and immunofluorescence co-localization, multiple orthogonal methods\",\n      \"pmids\": [\"12451597\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"PKC phosphorylates ARPC5 in neointimal smooth muscle cells, and this phosphorylation is required for rear polarization of the MTOC. A non-phosphorylatable ARPC5 mutant abolishes rear MTOC polarization and directional migration of neointimal SMCs, linking ARPC5 phosphorylation to cytoskeletal organization underlying cell polarity.\",\n      \"method\": \"Phosphoproteomic screening, mass spectrometry, RNA silencing of ARPC5, transfection with non-phosphorylatable ARPC5 mutant, PKC inhibition, immunofluorescence of MTOC orientation\",\n      \"journal\": \"The American journal of pathology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — phosphoproteomics plus functional rescue with phospho-dead mutant plus RNAi phenotype, multiple orthogonal methods in a single study\",\n      \"pmids\": [\"21281821\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"ARPC5 is a direct target of miR-133a; luciferase reporter assay confirmed direct binding. Silencing ARPC5 inhibits cell migration and invasion in HNSCC lines and causes reorganization of the actin cytoskeleton to a round, bleb-like morphology.\",\n      \"method\": \"Genome-wide gene expression analysis, bioinformatics, luciferase reporter assay (3'UTR), siRNA knockdown, migration/invasion assays, actin cytoskeleton imaging\",\n      \"journal\": \"International journal of oncology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — luciferase reporter validates direct miRNA target, functional KD confirms actin and migration phenotype, single lab\",\n      \"pmids\": [\"22378351\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"ARPC5 functions as a broadly acting translational suppressor in male germ cells: it inhibits translation initiation by blocking 80S ribosome formation and facilitates transport of mRNAs to chromatoid/P bodies. Loss of microRNA-dependent regulation of Arpc5 disrupts sequestration of germ cell mRNAs into translationally inert ribonucleoprotein particles, resulting in abnormal round spermatid differentiation and impaired fertility.\",\n      \"method\": \"Mouse genetics (loss-of-function), polysome profiling (80S formation assay), RNA immunoprecipitation, fluorescence imaging of chromatoid/P bodies, fertility assays\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal methods (polysome profiling, RIP, live imaging, genetic KO with defined cellular and organismal phenotype) establishing a non-canonical translational regulatory role\",\n      \"pmids\": [\"22447776\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"ARPC5 and ARPC5L isoforms differentially regulate Arp2/3 complex-dependent cell migration: both isoforms determine the structural stability of ArpC1 in actin branch junctions and influence protrusion characteristics and actin network ultrastructure. Additionally, ArpC5 isoforms differentially position Ena/VASP family proteins at the leading edge, and Ena/VASP mediates isoform-specific effects on actin assembly levels.\",\n      \"method\": \"Reverse genetics (CRISPR/siRNA), cellular cryo-electron tomography (cryo-ET), live-cell imaging, FRAP, immunofluorescence, migration assays\",\n      \"journal\": \"Science advances\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — cryo-ET structural biology combined with reverse genetics and live imaging, multiple orthogonal methods establishing mechanism\",\n      \"pmids\": [\"36662867\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"ARPC5 and ARPC5L isoforms play distinct roles in CD4 T cells: ARPC5 drives cytoplasmic actin dynamics after TCR stimulation and mediates nuclear actin polymerization triggered by DNA replication stress, while ARPC5L specifically drives nuclear actin polymerization upon TCR stimulation via a calcium-calmodulin-N-WASP signaling pathway.\",\n      \"method\": \"Isoform-specific siRNA knockdown, live-cell fluorescence imaging of actin (nuclear vs cytoplasmic), calcium-calmodulin pathway inhibitors, N-WASP inhibition/knockdown, cytokine expression assays\",\n      \"journal\": \"eLife\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — isoform-specific genetic depletion with pathway dissection (calcium-calmodulin-N-WASP), multiple orthogonal methods, defines distinct subcellular mechanistic roles\",\n      \"pmids\": [\"37162507\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"Germline biallelic null mutations in ARPC5 disrupt Arp2/3 complex conformation and function; reestablishment of ARPC5 expression in vitro rescues Arp2/3 complex conformation and functions. ARPC5 deficiency also selectively impairs IL-6 classical signaling but not IL-6 trans-signaling.\",\n      \"method\": \"Human genetics (biallelic null patients), in vitro complementation (ARPC5 re-expression), Arp2/3 complex functional assays, IL-6 signaling pathway dissection\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — human null mutations with in vitro rescue of Arp2/3 complex function, plus mechanistic pathway dissection of IL-6 signaling, multiple orthogonal methods\",\n      \"pmids\": [\"37349293\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"Cryo-EM structures at 2.9-Å resolution reveal that NPF binding to Arp2 is allosterically linked to the release of ArpC5's N-terminal tail from Arp2 and induces conformational changes in Arp2 including closure of its ATP-binding cleft and partial rotation/translation toward the active-complex position. This defines ArpC5's N-terminal tail as an inhibitory element whose release is part of the allosteric activation mechanism of Arp2/3 complex.\",\n      \"method\": \"Cryo-electron microscopy (cryo-EM) at 2.9-Å resolution, structural comparison of two states (with and without NPF bound to Arp2)\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — high-resolution cryo-EM structures with two distinct states and allosteric mechanism identified; single study but Tier 1 structural method\",\n      \"pmids\": [\"40042350\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"KLF4 transcriptionally activates ARPC5 by binding to its promoter region, as demonstrated by chromatin immunoprecipitation and luciferase reporter assay. ARPC5 in turn upregulates ADAM17 as a downstream effector to promote prostate cancer cell migration and invasion.\",\n      \"method\": \"Chromatin immunoprecipitation (ChIP), luciferase reporter assay, shRNA knockdown, ADAM17 overexpression rescue, xenograft mouse model\",\n      \"journal\": \"Apoptosis\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP and luciferase confirm direct transcriptional regulation; downstream ADAM17 link confirmed by rescue experiments; single lab\",\n      \"pmids\": [\"36881291\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"CPEB2 promotes ARPC5 mRNA stability through direct interaction, as shown by RNA immunoprecipitation and co-localization in the cytoplasm, and actinomycin D chase experiments demonstrating increased ARPC5 mRNA half-life when CPEB2 is expressed.\",\n      \"method\": \"RNA immunoprecipitation (RIP), FISH co-localization, actinomycin D mRNA stability assay, cycloheximide chase, shRNA knockdown/overexpression rescue\",\n      \"journal\": \"Journal of orthopaedic surgery and research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — RIP and mRNA stability assay establish post-transcriptional regulation mechanism; single lab, multiple orthogonal methods\",\n      \"pmids\": [\"37231521\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"TAGLN2 (transgelin-2) physically interacts with ARPC5 and promotes its expression, activating the MEK/ERK signaling pathway to drive pancreatic cancer cell proliferation, invasion, and metastasis. Silencing ARPC5 reverses TAGLN2 overexpression-induced effects.\",\n      \"method\": \"Co-immunoprecipitation (Co-IP), immunofluorescence, protein profiling, shRNA knockdown, MEK inhibitor (U0126), lentiviral overexpression, in vivo xenograft\",\n      \"journal\": \"Cellular signalling\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — Co-IP establishes interaction; downstream MEK/ERK pathway link and functional rescue with ARPC5 KD; single lab\",\n      \"pmids\": [\"38744388\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"Arp2/3 complexes containing Arpc5 (but not the Arpc5l isoform) are required for macrophage phagocytosis and killing of intracellular bacteria; loss of Arpc5 in the murine hematopoietic system leads to failure of macrophages to restrict microbial invasion, causing intestinal inflammation and demonstrating an isoform-specific role for ARPC5-containing Arp2/3 complexes in innate immune defense.\",\n      \"method\": \"Conditional knockout (hematopoietic-specific Arpc5 vs Arpc5l deletion in mice), phagocytosis assays, intracellular bacterial killing assays, histopathology, in vivo mouse model\",\n      \"journal\": \"bioRxiv\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — conditional KO with isoform specificity comparison and direct phagocytosis/killing assays; preprint, not yet peer-reviewed\",\n      \"pmids\": [\"bio_10.1101_2024.07.18.604111\"],\n      \"is_preprint\": true\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"Arpc5-containing Arp2/3 complexes in the actomyosin cortex act as a gatekeeper for membrane availability required for t-tubule growth in muscle cells; disruption of Arpc5 leads to enlarged t-tubules and impaired synchronization between plasma membrane depolarization and calcium release, causing muscle fatigue.\",\n      \"method\": \"Conditional postnatal knockout of Arpc5 in myofibers (mice), electron microscopy of t-tubules, calcium imaging, muscle fatigue/force measurements\",\n      \"journal\": \"bioRxiv\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — conditional KO with defined structural and functional phenotype in muscle; preprint, single study\",\n      \"pmids\": [\"bio_10.1101_2024.08.13.607563\"],\n      \"is_preprint\": true\n    }\n  ],\n  \"current_model\": \"ARPC5 (p16-Arc) is the smallest subunit of the seven-member Arp2/3 actin-nucleation complex, where its N-terminal tail contacts Arp2 and acts as an inhibitory element whose release—upon NPF binding to Arp2—is allosterically coupled to Arp2/3 activation; it exists as two isoforms (ARPC5A/ARPC5 and ARPC5B/ARPC5L) that are incorporated into compositionally distinct Arp2/3 complexes with different cellular functions: ARPC5 drives cytoplasmic actin dynamics, phagocytosis, and t-tubule membrane homeostasis, while ARPC5L mediates nuclear actin polymerization downstream of TCR/calcium-calmodulin-N-WASP signaling; both isoforms regulate actin branch junction stability, Ena/VASP positioning, and protrusion dynamics; ARPC5 is phosphorylated by MAPKAPK2 at Ser-77 and by PKC, the latter being required for rear MTOC polarization and directional migration; and ARPC5 has an unconventional translational suppressor role in spermatids where it blocks 80S ribosome formation and sequesters mRNAs into P bodies.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"ARPC5 (p16-Arc) is the smallest subunit of the Arp2/3 actin-nucleation complex, and within that complex its N-terminal tail functions as an autoinhibitory element whose release upon nucleation-promoting-factor binding to Arp2 is allosterically coupled to complex activation, with closure of the Arp2 ATP-binding cleft and rotation toward the active conformation [#8]. Mammalian cells contain two compositionally distinct Arp2/3 complexes built around the ARPC5 and ARPC5L isoforms, both incorporated into native complexes purified from neutrophils [#1], and these isoforms carry out divergent cellular functions: ARPC5-containing complexes stabilize ArpC1 at actin branch junctions, position Ena/VASP proteins at the leading edge, and shape protrusion dynamics during migration [#5], drive cytoplasmic actin dynamics after TCR stimulation while ARPC5L specifically mediates nuclear actin polymerization through a calcium-calmodulin-N-WASP pathway [#6]. ARPC5 activity is set post-translationally by phosphorylation: MAPKAPK2 phosphorylates the A isoform at Ser-77 [#0], and PKC phosphorylation is required for rear MTOC polarization and directional migration [#2]. Biallelic null mutations in ARPC5 disrupt Arp2/3 complex conformation and selectively impair IL-6 classical signaling, with re-expression rescuing complex function, defining ARPC5 deficiency as a cause of human disease [#7]. Beyond its structural role in actin nucleation, ARPC5 has an unconventional function as a translational suppressor in male germ cells, where it blocks 80S ribosome formation and routes mRNAs into chromatoid/P bodies, a microRNA-controlled activity required for normal spermatid differentiation and fertility [#4].\",\n  \"teleology\": [\n    {\n      \"year\": 2003,\n      \"claim\": \"Establishing that ARPC5 exists as two distinct isoforms both built into native Arp2/3 complexes revealed that mammalian cells assemble compositionally heterogeneous nucleation machines rather than a single uniform complex.\",\n      \"evidence\": \"Affinity purification of Arp2/3 from neutrophils, isoform-specific antibodies, and immunofluorescence co-localization in C2C12 cells\",\n      \"pmids\": [\"12451597\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not assign distinct functions to the two isoforms\", \"Tissue-specific isoform expression ratios not resolved\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Identification of MAPKAPK2 phosphorylation of ARPC5A at Ser-77, but not the B isoform, showed that the two isoforms are differentially regulated by signaling kinases even within intact complexes.\",\n      \"evidence\": \"In vitro kinase assays with recombinant MAPKAPK2, MALDI-MS, S77A mutagenesis, and Co-IP of native Arp2/3 from neutrophils\",\n      \"pmids\": [\"12829704\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Functional consequence of Ser-77 phosphorylation for actin nucleation not defined\", \"Upstream stimulus driving MK2-ARPC5 phosphorylation in vivo not established\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Linking PKC phosphorylation of ARPC5 to rear MTOC polarization connected a post-translational modification of this subunit to directional cell migration.\",\n      \"evidence\": \"Phosphoproteomics, ARPC5 RNAi, phospho-dead mutant rescue, and PKC inhibition in neointimal smooth muscle cells\",\n      \"pmids\": [\"21281821\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"PKC phospho-site on ARPC5 not mapped here\", \"Mechanistic link between ARPC5 phosphorylation and MTOC positioning unresolved\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Discovery that ARPC5 acts as a translational suppressor in spermatids established a non-canonical, actin-independent role distinct from its Arp2/3 function.\",\n      \"evidence\": \"Mouse loss-of-function genetics, polysome profiling, RNA immunoprecipitation, and P-body imaging with fertility assays\",\n      \"pmids\": [\"22447776\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular mechanism by which ARPC5 blocks 80S assembly unknown\", \"Whether this role requires Arp2/3 incorporation not addressed\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Validation of ARPC5 as a direct miR-133a target with migration/invasion phenotypes placed it within a cancer-relevant cytoskeletal regulatory axis.\",\n      \"evidence\": \"3'UTR luciferase reporter, siRNA knockdown, and migration/invasion plus actin morphology assays in HNSCC lines\",\n      \"pmids\": [\"22378351\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single-lab correlative cancer context\", \"Did not connect actin phenotype to a specific Arp2/3 mechanism\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Cryo-ET combined with reverse genetics defined how the ARPC5 and ARPC5L isoforms differentially set branch-junction stability and Ena/VASP positioning, giving isoform identity a structural and mechanistic basis in migration.\",\n      \"evidence\": \"CRISPR/siRNA depletion, cellular cryo-electron tomography, FRAP, and live-cell migration imaging\",\n      \"pmids\": [\"36662867\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Atomic basis for how isoforms alter ArpC1 stability not resolved\", \"How Ena/VASP is recruited isoform-specifically unclear\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Dissection in CD4 T cells showed ARPC5 and ARPC5L drive distinct cytoplasmic versus nuclear actin programs downstream of separable signaling inputs, demonstrating spatial division of labor between the isoforms.\",\n      \"evidence\": \"Isoform-specific siRNA, compartment-resolved live actin imaging, and calcium-calmodulin/N-WASP pathway perturbation\",\n      \"pmids\": [\"37162507\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How isoform composition is selected for nuclear vs cytoplasmic pools unknown\", \"Downstream transcriptional consequences of nuclear actin not detailed\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Human biallelic null mutations with in vitro rescue established ARPC5 as essential for proper Arp2/3 conformation and as a determinant of IL-6 classical signaling, defining a human disease connection.\",\n      \"evidence\": \"Patient genetics, ARPC5 re-expression complementation, Arp2/3 functional assays, and IL-6 signaling dissection\",\n      \"pmids\": [\"37349293\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism linking Arp2/3 to IL-6 classical vs trans-signaling not fully resolved\", \"Full clinical spectrum of deficiency not mapped\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Identification of KLF4 as a direct transcriptional activator and ADAM17 as a downstream effector placed ARPC5 in a defined transcription-to-invasion axis in prostate cancer.\",\n      \"evidence\": \"ChIP, promoter luciferase assays, shRNA knockdown, ADAM17 rescue, and xenografts\",\n      \"pmids\": [\"36881291\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single-lab cancer context\", \"Whether ADAM17 effect depends on Arp2/3 actin function unclear\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Demonstration that CPEB2 binds and stabilizes ARPC5 mRNA added a post-transcriptional layer controlling ARPC5 abundance.\",\n      \"evidence\": \"RNA immunoprecipitation, FISH co-localization, and actinomycin D mRNA stability chase with knockdown/overexpression rescue\",\n      \"pmids\": [\"37231521\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single-lab finding\", \"Physiological context where CPEB2 controls ARPC5 not established\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"TAGLN2 was shown to physically interact with ARPC5 and drive MEK/ERK-dependent tumor progression, linking ARPC5 to a proliferation/invasion signaling pathway.\",\n      \"evidence\": \"Co-IP, immunofluorescence, shRNA knockdown, MEK inhibition, and xenografts in pancreatic cancer\",\n      \"pmids\": [\"38744388\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single Co-IP-based interaction without structural mapping\", \"Direct vs indirect coupling of ARPC5 to MEK/ERK unresolved\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Isoform-resolved conditional knockouts defined ARPC5-specific (not ARPC5L) roles in macrophage phagocytosis/bacterial killing and in t-tubule membrane homeostasis, extending isoform specialization to innate immunity and muscle physiology.\",\n      \"evidence\": \"Hematopoietic- and myofiber-specific conditional Arpc5 deletion, phagocytosis/killing assays, t-tubule EM, and calcium/fatigue measurements (preprints)\",\n      \"pmids\": [\"bio_10.1101_2024.07.18.604111\", \"bio_10.1101_2024.08.13.607563\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Both findings are preprints not yet peer-reviewed\", \"Molecular basis for ARPC5 over ARPC5L preference in these tissues unknown\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"High-resolution cryo-EM structures resolved how NPF binding to Arp2 triggers release of the ARPC5 N-terminal tail, defining it as an inhibitory element released during allosteric activation of the complex.\",\n      \"evidence\": \"2.9-Å cryo-EM structures comparing NPF-bound and unbound Arp2 states\",\n      \"pmids\": [\"40042350\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether ARPC5 vs ARPC5L tails differ in this inhibitory mechanism not addressed\", \"Kinetics of tail release during nucleation not measured\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How a cell selects ARPC5 versus ARPC5L for incorporation into Arp2/3 complexes, and how this choice is coordinated with the kinase, microRNA, and transcriptional inputs that regulate ARPC5, remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No mechanism for isoform selection during complex assembly\", \"Integration of phospho-regulation with isoform-specific functions not established\", \"Relationship between the actin-nucleation and translational-suppressor roles unknown\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0005198\", \"supporting_discovery_ids\": [1, 5, 8]},\n      {\"term_id\": \"GO:0008092\", \"supporting_discovery_ids\": [5, 8]},\n      {\"term_id\": \"GO:0045182\", \"supporting_discovery_ids\": [4]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005856\", \"supporting_discovery_ids\": [1, 5]},\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [6]},\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [6]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [6, 7]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [2, 11]}\n    ],\n    \"complexes\": [\"Arp2/3 complex\"],\n    \"partners\": [\"ARPC1\", \"TAGLN2\", \"CPEB2\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":5,"faith_total":5,"faith_pct":100.0}}